Clinical Trial Update: AZD1656 in Transplantation With Diabetes tO PromoTe Immune TOleraNce [Phase 2]

View source ↗

Summary

Phase 2 trial of AZD1656 in transplantation to promote immune tolerance in patients with Type 2 diabetes undergoing kidney transplant has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease
• Type 2 Diabetes Mellitus

Drugs mentioned

• AZD1656

Snippet

Sponsor: Queen Mary University of London | Conditions: Type 2 Diabetes, Diabetes Mellitus, Type 2 | Phase 2 | Status: COMPLETED